Progress in Addressing Hyperlipidemia in the Primary Prevention Setting
A Q&A with Steven E. Nissen, M.D., M.A.C.C.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Biosimilars in 2025: A year of firsts
2
What IRA drug prices will mean for PBMs, health plans and patients
3
Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026
4
Low uptake of shingles vaccine despite strong value proposition for older adults
5
